4//SEC Filing
Wiley Michael J 4
Accession 0001628280-19-014124
CIK 0001576280other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:53 PM ET
Size
18.9 KB
Accession
0001628280-19-014124
Insider Transaction Report
Form 4
Wiley Michael J
Chief Legal Officer
Transactions
- Gift
COMMON STOCK
2019-10-10+10,000→ 10,000 total(indirect: By Trust) - Exercise/Conversion
COMMON STOCK
2019-11-11$4.18/sh+6,779$28,336→ 179,516 total - Sale
COMMON STOCK
2019-11-11$72.12/sh−2,898$209,004→ 176,618 total - Exercise/Conversion
STOCK OPTION (RIGHT TO BUY)
2019-11-11−6,779→ 106,781 totalExercise: $4.18Exp: 2027-07-13→ COMMON STOCK (6,779 underlying) - Gift
COMMON STOCK
2019-10-10−40,000→ 172,737 total - Gift
COMMON STOCK
2019-10-10+10,000→ 10,000 total(indirect: By Trust) - Gift
COMMON STOCK
2019-10-10+10,000→ 10,000 total(indirect: By Trust) - Gift
COMMON STOCK
2019-10-10+10,000→ 10,000 total(indirect: By Trust) - Sale
COMMON STOCK
2019-11-11$73.08/sh−3,881$283,623→ 172,737 total
Footnotes (5)
- [F1]The Reporting Person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, if any.
- [F2]These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The shares sold were acquired contemporaneously upon the cashless exercise of stock options at an exercise price of $4.18 per share.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.71 to $72.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.72 to $73.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on April 23, 2017.
Documents
Issuer
Guardant Health, Inc.
CIK 0001576280
Entity typeother
Related Parties
1- filerCIK 0001753789
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 4:53 PM ET
- Size
- 18.9 KB